61 – 70 of 191
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2018
-
Mark
The use of synthetic peptides for detection of anti-citrullinated protein antibodies in rheumatoid arthritis
- Contribution to journal › Article
-
Mark
Impact of Drug Induced Remission in Rheumatoid Arthritis
(2018)
- Thesis › Doctoral thesis (compilation)
-
Mark
Sex-based differences in association between circulating T cell subsets and disease activity in untreated early rheumatoid arthritis patients
- Contribution to journal › Article
-
Mark
Effects of Treatment with Adalimumab on Blood Lipid Levels and Atherosclerosis in Patients with Rheumatoid Arthritis
- Contribution to journal › Article
-
Mark
The predictive role of ultrasound-detected tenosynovitis and joint synovitis for flare in patients with rheumatoid arthritis in stable remission. Results of an Italian multicentre study of the Italian Society for Rheumatology Group for Ultrasound : The STARTER study
- Contribution to journal › Article
- 2017
-
Mark
Arthritis management in primary care - A study of physiotherapists' current practice, educational needs and adherence to national guidelines
- Contribution to journal › Article
-
Mark
Methotrexate reduces vaccine-specific immunoglobulin levels but not numbers of circulating antibody-producing B cells in rheumatoid arthritis after vaccination with a conjugate pneumococcal vaccine
- Contribution to journal › Article
-
Mark
Body mass does not impact the clinical response to intravenous abatacept in patients with rheumatoid arthritis. Analysis from the “pan-European registry collaboration for abatacept (PANABA)
- Contribution to journal › Article
-
Mark
Blood chemokine profile in untreated early rheumatoid arthritis : CXCL10 as a disease activity marker
- Contribution to journal › Article
-
Mark
Severe extraarticular manifestations in a community based cohort of patients with rheumatoid arthritis : Risk factors and incidence in relation to treatment with tumor necrosis factor inhibitors
- Contribution to journal › Article
